Identification Of Targetable Activating Mutations In Canine Acanthomatous Ameloblastoma. Principal Investigator: Santiago Peralta, Dvm, Davdc

Sep 10, 2021 | Articles, News

The Foundation is pleased to announce a new publication by Dr. Peralta et al regarding the genetic mutations of canine acanthomatous ameloblastoma in dogs.  Funding of grants from the Foundation provide opportunities for new discoveries in veterinary dentistry and information that may have future benefits for pets and people.

Peralta S, McCleary-Wheeler AL, Duhamel GE, Heikinheimo K, Grenier JK. Ultra-frequent HRAS p.Q61R somatic mutation in canine acanthomatous ameloblastoma reveals pathogenic similarities with human ameloblastoma. Vet Comp Oncol. 2019;